Surgical Hemostat Stops Bleeding Quickly

A liquid sprayable hydrogel serves as an adjunct to hemostasis in surgical procedures-- except for neurologic, ophthalmic, and urologic surgeries—stopping difficult bleeding quickly.

Called CoStasis, the hemostat is comprised of a ready-to-use suspension of collagen and thrombin, which is mixed with a patient's plasma and then sprayed directly on the bleeding site. CoStasis remains intact during the critical wound-healing period and is resorbed by the body within 30 days. Because CoStasis uses the patient's own plasma, there is no potential contamination risk from using pooled blood-derived products. The hemostat was developed by Cohesion Technologies, Inc. (Palo Alto, CA, USA). CoStasis is distributed by United States Surgical (Norwalk, CT, USA) throughout the world except for part of Asia.

"Improving surgical outcomes and patients' quality of life is what Cohesion Technologies' products are about,” said David Foster, chief executive officer. "CoStasis is a highly effective versatile product that is used in traditional, open surgical procedures as well as in minimally invasive procedures.”





Related Links:
Cohesion Technologies
U.S. Surgical